FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Titterton Lewis H jr
  2. Issuer Name and Ticker or Trading Symbol
Anixa Biosciences Inc [ANIX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250
3. Date of Earliest Transaction (Month/Day/Year)
09/20/2019
(Street)

SAN JOSE, CA 95118
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option $ 0.67 09/20/2019   D(1)     30,000   (2) 09/19/2022 Common Stock 30,000 (1) 0 D  
Employee Stock Option $ 2.575 09/20/2019   A(1)   30,000     (2) 09/19/2022 Common Stock 30,000 (1) 30,000 D  
Employee Stock Option $ 0.67 09/20/2019   D(1)     40,000   (3) 02/15/2023 Common Stock 40,000 (1) 0 D  
Employee Stock Option $ 2.575 09/20/2019   A(1)   40,000     (3) 02/15/2023 Common Stock 40,000 (1) 40,000 D  
Employee Stock Option $ 0.67 09/20/2019   D(1)     16,000   (4) 12/31/2022 Common Stock 16,000 (1) 0 D  
Employee Stock Option $ 2.575 09/20/2019   A(1)   16,000     (4) 12/31/2022 Common Stock 16,000 (1) 16,000 D  
Employee Stock Option $ 0.67 09/20/2019   D(1)     6,000   (5) 07/17/2027 Common Stock 6,000 (1) 0 D  
Employee Stock Option $ 0.82 09/20/2019   A(1)   6,000     (5) 07/17/2027 Common Stock 6,000 (1) 6,000 D  
Employee Stock Option $ 0.67 09/20/2019   D(1)     120,000   (6) 11/08/2023 Common Stock 120,000 (1) 0 D  
Employee Stock Option $ 2.575 09/20/2019   A(1)   120,000     (6) 11/08/2023 Common Stock 120,000 (1) 120,000 D  
Employee Stock Option $ 0.67 09/20/2019   D(1)     16,000   (7) 12/31/2023 Common Stock 16,000 (1) 0 D  
Employee Stock Option $ 2.575 09/20/2019   A(1)   16,000     (7) 12/31/2023 Common Stock 16,000 (1) 16,000 D  
Employee Stock Option $ 0.67 09/20/2019   D(1)     16,000   (8) 01/02/2025 Common Stock 16,000 (1) 0 D  
Employee Stock Option $ 2.575 09/20/2019   A(1)   16,000     (8) 01/02/2025 Common Stock 16,000 (1) 16,000 D  
Employee Stock Option $ 0.67 09/20/2019   D(1)     16,000   (9) 01/14/2026 Common Stock 16,000 (1) 0 D  
Employee Stock Option $ 2.92 09/20/2019   A(1)   16,000     (9) 01/14/2026 Common Stock 16,000 (1) 16,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Titterton Lewis H jr
C/O ANIXA BIOSCIENCES, INC.
3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE, CA 95118
  X      

Signatures

 /s/ Lewis H. Titterton, Jr.   09/20/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the "old" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options.
(2) The option was originally granted on September 19, 2012 and vested as follows: one third immediately and two thirds annually beginning on September 19, 2013.
(3) The option was originally granted on February 15, 2013 and vested as follows: one third immediately and two thirds annually beginning on February 15, 2014.
(4) The option was originally granted on March 28, 2013 and vested in in four (4) equal installments on each March 31, 2013, June 30, 2013, September 30, 2013 and December 31, 2013.
(5) The option was originally granted on July 17, 2017 and vests and become exercisable in two equal installments on each September 30, 2017 and December 31, 2017.
(6) The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013.
(7) The option was originally granted on January 2, 2014 and vested in four (4) equal installments on each of March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014.
(8) The option was originally granted on January 2, 2015 and vested in four (4) equal installments on each of March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015.
(9) The option was originally granted on February 18, 2016 and vested in four (4) equal installments on each of March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.